CLINICAL ROLE -
FDA Grants Priority Review to Hemophilia A With Factor VIII Inhibitors Drug
Emicizumab prophylaxis is designed to bring together factors IXa and X to restore the blood clotting process.
Read More
Multiple Sclerosis Mortality Rates Elevated in Armed Forces
Risk of death from MS higher among men in military across 3 successive decades.
HIV Viral Load Rebound Possible Among Pregnant Women Who Achieved Suppression
HIV rebound detected within 1 day before delivery in 50% of study participants.
Trending News Today: Consuming High Doses of Vitamin B Doubles Risk of Lung Cancer Among Men
Top news of the day from across the health care landscape.
Dermira Obtains Licensing Agreement for Atopic Dermatitis Drug
Lebrikizumab is a monoclonal antibody designed to specifically target interleukin 13 for patients with moderate-to-severe atopic dermatitis.
Dermira Obtains Exclusive Rights for Commercialization of Atopic Dermatitis Drug
Lebrikizumab is a monoclonal antibody designed to treat atopic dermatitis.
Scientists Uncover Underlying Mechanisms of Immune Checkpoint Inhibitors
T cell responses in different tumor models are fundamentally similar.
FDA Approves Label Change for HIV Drug
Odefsey label updated to include updated data from clinical trials examining patients who switched from tenofovir disoproxil fumarate-based regimens.
Odefsey Receives Approved Label Change from FDA
Changes include additional trial data in virologically-suppressed adults with HIV-1 infection.
Opioid Use for Pain Management Higher Among Cancer Survivors
Study finds greater rate of opioid prescribing among cancer survivors 10 or more years past their cancer diagnosis.
Discuss the Importance of Treating the Whole Patient Rather than Only the Disease?
Marc O’Connor, chief operating officer at Curant Health, explains why treating the whole patient rather than just their specific disease is so important.
FDA Accepts Review of Biologics License Application Resubmission Bleeding Event Treatment
Andexanet alfa is the first compound being investigated as an antidote for Factor Xa inhibitors.
Chronic Inflammation in Rheumatoid Arthritis Attributed to Hibernating Cells
Hibernating innate lymphoid cells allows inflammation to persist in rheumatoid arthritis.
Trending News Today: Ovarian Cancer Patient Awarded $417 Million in J&J Baby Powder Lawsuit
Exploring the Role of Citrate Transport Pathway in Liver Cancer Growth
Understudied gene provides insight into how liver cancer cells gain the nutrition necessary to proliferate.
Multiple Sclerosis Drug Costs Called into Question
Legislative investigation seeks information from 7 drug makers on costs for MS medications.
Biosimilar of Humalog Shows Non-Inferiority in Type 1 Diabetes
Novel diabetes biosimilar shows similar safety, efficacy, and immunogenicity to the reference drug.
FDA Accepts Supplemental Biologics License Application for Lymphoma Drug
Brentuximab vedotin under evaluation for the treatment of cutaneous T-cell lymphoma.
Targeting ALT Cancers Via Replication Stress at Telomeres
The novel strategy could be more effective and less toxic than current chemotherapy drugs treating alternative lengthening telomere cancers.
Small Financial Incentives Promote Primary Care Visits Among Low-Income Adults
Incentives for newly covered low-income patients may also reduce long-term costs.
Trending News Today: Health Plan Options Non-Existent After Anthem's Exit from California Marketplace
Pharmacy Intervention Program Will Save NHS England Millions
Pharmacy service was launched 6 years ago to help patients remain adherent to treatment regimens.
Continued Opioid Prescription Fills Higher Among Cancer Survivors
Managing chronic pain after a cancer diagnosis remains a challenge.
Treatment-Resistant Breast Cancer May Have Met Its Match with First-In-Class Drugs
The new compounds may lead to a highly effective, next-line treatment for estrogen receptor-positive breast cancer.
Cherokee Nation Sets Blueprint for Elimination of Hepatitis C
Hepatitis C elimination program screens more than 45K individuals in first 2 years of launch.
Trending News Today: Mylan Reaches Settlement, Pays $465 Million in EpiPen Suit
Gut Bacteria Reduces Inflammation, Demyelination in Autoimmune Disease
A gut microbe may play a role in the treatment of multiple sclerosis in the future.
Cosentyx Plateaus as Non-TNF Agents Prepare to Dominate in Psoriatic Arthritis
Research finds that a robust pipeline of PsA agents will put pressure on Cosentyx.
BioMarin to Include Additional Phase 3 Trial for Hemophilia A Gene Therapy
Phase 3 program to examine novel gene therapy that treats the cause of hemophilia A.
Novel PET Tracer for Prostate Cancer Shows Promise
Study is the first to provide evidence that proton-coupled amino acid transporters can be elevated in prostate cancer.